Maryland State Retirement & Pension System Sells 724 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Maryland State Retirement & Pension System decreased its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS) by 4.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,005 shares of the company’s stock after selling 724 shares during the quarter. Maryland State Retirement & Pension System’s holdings in Avanos Medical were worth $319,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Alberta Investment Management Corp grew its holdings in Avanos Medical by 16.6% during the 4th quarter. Alberta Investment Management Corp now owns 413,418 shares of the company’s stock worth $9,273,000 after acquiring an additional 58,826 shares during the period. Tidal Investments LLC bought a new stake in Avanos Medical in the first quarter valued at about $439,000. BNP Paribas Financial Markets increased its holdings in Avanos Medical by 314.4% in the first quarter. BNP Paribas Financial Markets now owns 53,583 shares of the company’s stock valued at $1,067,000 after purchasing an additional 40,653 shares during the last quarter. Norges Bank acquired a new position in Avanos Medical in the fourth quarter valued at about $7,016,000. Finally, Tributary Capital Management LLC boosted its holdings in Avanos Medical by 7.5% during the first quarter. Tributary Capital Management LLC now owns 742,455 shares of the company’s stock worth $14,782,000 after buying an additional 51,865 shares during the last quarter. 95.17% of the stock is owned by institutional investors.

Avanos Medical Trading Down 0.7 %

Shares of NYSE AVNS opened at $23.91 on Thursday. Avanos Medical, Inc. has a twelve month low of $17.24 and a twelve month high of $24.77. The stock has a market cap of $1.10 billion, a price-to-earnings ratio of -17.98 and a beta of 0.91. The company has a quick ratio of 1.49, a current ratio of 2.28 and a debt-to-equity ratio of 0.13. The company’s fifty day moving average is $22.31 and its 200-day moving average is $20.45.

Avanos Medical (NYSE:AVNS) last posted its earnings results on Wednesday, July 31st. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.05. The firm had revenue of $171.70 million during the quarter, compared to analysts’ expectations of $170.67 million. Avanos Medical had a return on equity of 4.48% and a net margin of 1.13%. The company’s revenue was up 1.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.24 earnings per share. Equities research analysts predict that Avanos Medical, Inc. will post 1.39 EPS for the current year.

Analysts Set New Price Targets

Separately, StockNews.com raised Avanos Medical from a “hold” rating to a “buy” rating in a research note on Saturday, May 11th.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.